Concepedia

Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus

Chia‐Hsuin Chang, Jou‐Wei Lin, Li‐Chiu Wu, Mei‐Shu Lai, Lee‐Ming Chuang

The Journal of Clinical Endocrinology & Metabolism · 2012 · 129 citations · 15 references

DOIFull text

Open access

Abstract

The results showed that sulfonylureas and glinides increased the risk for overall cancer, but to a lesser extent than insulin. Therapies that are associated with cancer risks certainly require further investigation.

References

15

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson et al. · New England Journal of Medicine · 2011 · 2.7K citations · Full text

Diabetes and Cancer

Edward L. Giovannucci, David M. Harlan, Michael C. Archer et al. · Diabetes Care · 2010 · 2.2K citations · Full text

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

Wayne A. Ray · American Journal of Epidemiology · 2003 · 1.6K citations · Full text

, , +18

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

C. J. Currie, C Poole, E.A.M. Gale · Diabetologia · 2009 · 1.1K citations · Full text

, , +7

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

Linda E. Lévesque, J. A Hanley, Abbas Kezouh et al. · BMJ · 2010 · 1.1K citations

, , +16